Skip to main content
. 2010 Oct 8;9:273. doi: 10.1186/1475-2875-9-273

Figure 3.

Figure 3

Plasma artesunate (a) and dihydroartemisinin (b) concentrations at 1 hour of the first dose in day 1 in patients with sensitive (S) and recrudescence (R) response. Dot lines represent the lower and upper level of 95% CI defined in the sensitive group.